Patent · US Active

Pharmaceutical compositions comprising 5-azacytidine monohydrate

US8779117B2 · kind B2 · utility

0Cited by

26References

17Claims

0Family size

Assignee

Pharmion LLC · US

Inventors

Dumitru Ionescu · Ann Arbor, US
Peter Blumbergs · Royal Oak, US
Gary L. Silvey · Overland Park, US

Key dates

Filing date	May 25, 2010
Grant date	Jul 15, 2014
Priority date	—
Expiry date	Jul 19, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are pharmaceutical compositions or dosage forms comprising crystalline 5-azacytidine monohydrate. The pharmaceutical compositions or dosage forms provided herein may be used for oral administration in the treatment of diseases, including the treatment of myelodysplastic syndromes (MDS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.